Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Inoperable Malignant Central Airway Obstruction
NCT06306638Phase 2Recruiting
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Oct 2024
- Primary completion
- Oct 2029
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of verteporfin in malignant central airway obstruction, sponsored by Roswell Park Comprehensive Cancer Center. Started Oct 2024; status: recruiting.
02
Drugs
verteporfin
03
Conditions
malignant central airway obstruction
Beyond the preview
Go deeper on NCT06306638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306638.